View in EDS HTML Full Text PDF Full Text

Assessing contribution of effect in oncology combination therapies: lessons learned to inform and optimize future registrational trial designs.

Saved in:
Bibliographic Details
Title: Assessing contribution of effect in oncology combination therapies: lessons learned to inform and optimize future registrational trial designs.
Authors: Andrews HS; Friends of Cancer Research, Washington, DC, 20036, United States., Agnihotram R; Johnson and Johnson Innovative Medicines, Raritan, NJ, 08869, United States., Blumenthal G; Pfizer, Inc, New York, NY, 10001, United States., Bullock J; GSK, Philadelphia , PA, 19112, United States., Collins G; Friends of Cancer Research, Washington, DC, 20036, United States., Doherty GJ; AstraZeneca, Cambridge, United Kingdom., Farago AF; Amgen, Inc, Thousand Oaks, CA, 91320, United States., Ishii Y; Independent Patient Advocate, Washington, DC, 20036, United States., Kasichayanula S; Gilead Sciences., Inc, Forester City, CA, 94404, United States., LeBlanc M; Fred Hutchinson Cancer Center, Seattle, WA, 98109, United States., Levi-D'Ancona E; Friends of Cancer Research, Washington, DC, 20036, United States., Li C; Genentech, Inc, San Francisco, CA, 94080, United States., McCullough K; GSK, Philadelphia , PA, 19112, United States., Morrow PKP; Takeda Pharmaceuticals, Inc, Cambridge, MA, 02142, United States., Navarro B; Friends of Cancer Research, Washington, DC, 20036, United States., Sandhu P; Daiichi Sankyo, Basking Ridge, NJ, 07920, United States., Shah S; Johnson and Johnson Innovative Medicines, Raritan, NJ, 08869, United States., Sharon E; Dana-Farber Cancer Institute, Boston, MA, 02215, United States., Su Z; Marengo Therapeutics, Cambridge, MA, 02139, United States., Vallett C; Independent Patient Advocate, Washington, DC, 20036, United States., Villalobos Y; Eli Lilly and Company, Indianapolis, IN, 46285, United States., Allen JD; Friends of Cancer Research, Washington, DC, 20036, United States., Stewart MD; Friends of Cancer Research, Washington, DC, 20036, United States.
Source: The oncologist [Oncologist] 2026 Jun 06; Vol. 31 (7).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42236300
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Assessing contribution of effect in oncology combination therapies: lessons learned to inform and optimize future registrational trial designs.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Andrews+HS%22">Andrews HS</searchLink>; Friends of Cancer Research, Washington, DC, 20036, United States.<br /><searchLink fieldCode="AU" term="%22Agnihotram+R%22">Agnihotram R</searchLink>; Johnson and Johnson Innovative Medicines, Raritan, NJ, 08869, United States.<br /><searchLink fieldCode="AU" term="%22Blumenthal+G%22">Blumenthal G</searchLink>; Pfizer, Inc, New York, NY, 10001, United States.<br /><searchLink fieldCode="AU" term="%22Bullock+J%22">Bullock J</searchLink>; GSK, Philadelphia , PA, 19112, United States.<br /><searchLink fieldCode="AU" term="%22Collins+G%22">Collins G</searchLink>; Friends of Cancer Research, Washington, DC, 20036, United States.<br /><searchLink fieldCode="AU" term="%22Doherty+GJ%22">Doherty GJ</searchLink>; AstraZeneca, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Farago+AF%22">Farago AF</searchLink>; Amgen, Inc, Thousand Oaks, CA, 91320, United States.<br /><searchLink fieldCode="AU" term="%22Ishii+Y%22">Ishii Y</searchLink>; Independent Patient Advocate, Washington, DC, 20036, United States.<br /><searchLink fieldCode="AU" term="%22Kasichayanula+S%22">Kasichayanula S</searchLink>; Gilead Sciences., Inc, Forester City, CA, 94404, United States.<br /><searchLink fieldCode="AU" term="%22LeBlanc+M%22">LeBlanc M</searchLink>; Fred Hutchinson Cancer Center, Seattle, WA, 98109, United States.<br /><searchLink fieldCode="AU" term="%22Levi-D'Ancona+E%22">Levi-D'Ancona E</searchLink>; Friends of Cancer Research, Washington, DC, 20036, United States.<br /><searchLink fieldCode="AU" term="%22Li+C%22">Li C</searchLink>; Genentech, Inc, San Francisco, CA, 94080, United States.<br /><searchLink fieldCode="AU" term="%22McCullough+K%22">McCullough K</searchLink>; GSK, Philadelphia , PA, 19112, United States.<br /><searchLink fieldCode="AU" term="%22Morrow+PKP%22">Morrow PKP</searchLink>; Takeda Pharmaceuticals, Inc, Cambridge, MA, 02142, United States.<br /><searchLink fieldCode="AU" term="%22Navarro+B%22">Navarro B</searchLink>; Friends of Cancer Research, Washington, DC, 20036, United States.<br /><searchLink fieldCode="AU" term="%22Sandhu+P%22">Sandhu P</searchLink>; Daiichi Sankyo, Basking Ridge, NJ, 07920, United States.<br /><searchLink fieldCode="AU" term="%22Shah+S%22">Shah S</searchLink>; Johnson and Johnson Innovative Medicines, Raritan, NJ, 08869, United States.<br /><searchLink fieldCode="AU" term="%22Sharon+E%22">Sharon E</searchLink>; Dana-Farber Cancer Institute, Boston, MA, 02215, United States.<br /><searchLink fieldCode="AU" term="%22Su+Z%22">Su Z</searchLink>; Marengo Therapeutics, Cambridge, MA, 02139, United States.<br /><searchLink fieldCode="AU" term="%22Vallett+C%22">Vallett C</searchLink>; Independent Patient Advocate, Washington, DC, 20036, United States.<br /><searchLink fieldCode="AU" term="%22Villalobos+Y%22">Villalobos Y</searchLink>; Eli Lilly and Company, Indianapolis, IN, 46285, United States.<br /><searchLink fieldCode="AU" term="%22Allen+JD%22">Allen JD</searchLink>; Friends of Cancer Research, Washington, DC, 20036, United States.<br /><searchLink fieldCode="AU" term="%22Stewart+MD%22">Stewart MD</searchLink>; Friends of Cancer Research, Washington, DC, 20036, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229607837%22">The oncologist</searchLink> [Oncologist] 2026 Jun 06; Vol. 31 (7).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9607837 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-490X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210837159%22">10837159 </searchLink><i>NLM ISO Abbreviation: </i>Oncologist <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42236300
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/oncolo/oyag222
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Assessing contribution of effect in oncology combination therapies: lessons learned to inform and optimize future registrational trial designs.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Andrews HS
      – PersonEntity:
          Name:
            NameFull: Agnihotram R
      – PersonEntity:
          Name:
            NameFull: Blumenthal G
      – PersonEntity:
          Name:
            NameFull: Bullock J
      – PersonEntity:
          Name:
            NameFull: Collins G
      – PersonEntity:
          Name:
            NameFull: Doherty GJ
      – PersonEntity:
          Name:
            NameFull: Farago AF
      – PersonEntity:
          Name:
            NameFull: Ishii Y
      – PersonEntity:
          Name:
            NameFull: Kasichayanula S
      – PersonEntity:
          Name:
            NameFull: LeBlanc M
      – PersonEntity:
          Name:
            NameFull: Levi-D'Ancona E
      – PersonEntity:
          Name:
            NameFull: Li C
      – PersonEntity:
          Name:
            NameFull: McCullough K
      – PersonEntity:
          Name:
            NameFull: Morrow PKP
      – PersonEntity:
          Name:
            NameFull: Navarro B
      – PersonEntity:
          Name:
            NameFull: Sandhu P
      – PersonEntity:
          Name:
            NameFull: Shah S
      – PersonEntity:
          Name:
            NameFull: Sharon E
      – PersonEntity:
          Name:
            NameFull: Su Z
      – PersonEntity:
          Name:
            NameFull: Vallett C
      – PersonEntity:
          Name:
            NameFull: Villalobos Y
      – PersonEntity:
          Name:
            NameFull: Allen JD
      – PersonEntity:
          Name:
            NameFull: Stewart MD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 06
              Text: 2026 Jun 06
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1549-490X
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: The oncologist
              Type: main
ResultId 1